Whole transcriptome RNA-seq analysis: Tumorigenesis and metastasis of melanoma

Gene

Volumn 548, Issue 2, 2014, Pages 234-243

  Zhao, Hua ^a   Li, Yongjun ^b   Wang, Shaobin ^b   Yang, Yadong ^b   Wang, Junyun ^b   Ruan, Xiuyan ^b   Yang, Yaran ^b   Cai, Kan ^b   Zhang, Bing ^b   Cui, Peng ^b   Yan, Jiangwei ^b   Zhao, Yongliang ^b   Wakeland, Edward K ^b,c   Li, Quanzhen ^c   Hu, Songnian ^b   Fang, Xiangdong ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Chinese Academy of Sciences   (China)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Melanoma; Metastasis; Next generation sequencing; Transcriptome; Tumorigenesis

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 8; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR ONECUT; TRANSCRIPTION FACTOR ONECUT 1; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME 11; CHROMOSOME 12; CHROMOSOME 14; CHROMOSOME 9; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; MALE; MELANOCYTE; MELANOMA; MELANOMA CELL LINE; MELANOMA METASTASIS; NEWBORN; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; RNA ANALYSIS; RNA SEQUENCE; SEQUENCE ANALYSIS; SKIN CARCINOGENESIS; TRANSCRIPTOMICS;

MELANOMA; METASTASIS; NEXT-GENERATION SEQUENCING; TRANSCRIPTOME; TUMORIGENESIS;

CARCINOGENESIS; CELL LINE, TUMOR; CHROMOSOMES, HUMAN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; NEOPLASM METASTASIS; SEQUENCE ANALYSIS, RNA; TRANSCRIPTOME;

EID: 84904969252     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.07.038     Document Type: Article

References (38)

1. Alonso S.R., Tracey L., Ortiz P., Perez-Gomez B., Palacios J., Pollan M., Linares J., Serrano S., Saez-Castillo A.I., Sanchez L., et al. A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis. Cancer Res. 2007, 67:3450-3460.
2. An J., Wan H., Zhou X., Hu D.N., Wang L., Hao L., Yan D., Shi F., Zhou Z., Wang J., et al. A comparative transcriptomic analysis of uveal melanoma and normal uveal melanocyte. PLoS One 2011, 6:e16516.
3. Becker B., Roesch A., Hafner C., Stolz W., Dugas M., Landthaler M., Vogt T. Discrimination of melanocytic tumors by cDNA array hybridization of tissues prepared by laser pressure catapulting. J. Invest. Dermatol. 2004, 122:361-368.
4. Berger M., Levin J., Vijayendran K., Sivachenko A., Adiconis X., Maguire J., Johnson L., Robinson J., Verhaak R., Sougnez C. Integrative analysis of the melanoma transcriptome. Genome Res. 2010, 20:413.
5. Blencowe B.J., Ahmad S., Lee L.J. Current-generation high-throughput sequencing: deepening insights into mammalian transcriptomes. Genes Dev. 2009, 23:1379-1386.
6. Bonaldi L., Midena E., Filippi B., Tebaldi E., Marcato R., Parrozzani R., Amadori A. FISH analysis of chromosomes 3 and 6 on fine needle aspiration biopsy samples identifies distinct subgroups of uveal melanomas. J. Cancer Res. Clin. Oncol. 2008, 134:1123-1127.
7. Bradford J.R., Hey Y., Yates T., Li Y., Pepper S.D., Miller C.J. A comparison of massively parallel nucleotide sequencing with oligonucleotide microarrays for global transcription profiling. BMC Genomics 2010, 11:282.
8. Bruyn R.P., Stoof J.C. The quinolinic acid hypothesis in Huntington's chorea. J. Neurol. Sci. 1990, 95:29-38.
9. Chen C.H., Chen R.J. Prevalence of telomerase activity in human cancer. J. Formos. Med. Assoc. 2011, 110:275-289.
10. CHO W.C. Tumor diversity: implementing NGS into clinic. Gastric Breast Cancer 2012, 11:121-126.
11. Cho W., Ziogas D.E., Katsios C., Roukos D.H. Emerging personalized oncology: sequencing and systems strategies. Future Oncol. 2012, 8:637-641.
12. Estler M., Boskovic G., Denvir J., Miles S., Primerano D.A., Niles R.M. Global analysis of gene expression changes during retinoic acid-induced growth arrest and differentiation of melanoma: comparison to differentially expressed genes in melanocytes vs melanoma. BMC Genomics 2008, 9:478.
13. Flockhart R.J., Webster D.E., Qu K., Mascarenhas N., Kovalski J., Kretz M., Khavari P.A. BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration. Genome Res. 2012, 22:1006-1014.
14. Gallagher P.G., Bao Y., Prorock A., Zigrino P., Nischt R., Politi V., Mauch C., Dragulev B., Fox J.W. Gene expression profiling reveals cross-talk between melanoma and fibroblasts: implications for host-tumor interactions in metastasis. Cancer Res. 2005, 65:4134-4146.
15. Hoek K., Rimm D.L., Williams K.R., Zhao H., Ariyan S., Lin A., Kluger H.M., Berger A.J., Cheng E., Trombetta E.S., et al. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res. 2004, 64:5270-5282.
16. Kozlowski J.M., Hart I.R., Fidler I.J., Hanna N. A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. J. Natl. Cancer Inst. 1984, 72:913-917.
17. Lehner F., Kulik U., Klempnauer J., Borlak J. The hepatocyte nuclear factor 6 (HNF6) and FOXA2 are key regulators in colorectal liver metastases. FASEB J. 2007, 21:1445-1462.
18. Mandruzzato S., Callegaro A., Turcatel G., Francescato S., Montesco M.C., Chiarion-Sileni V., Mocellin S., Rossi C.R., Bicciato S., Wang E., et al. A gene expression signature associated with survival in metastatic melanoma. J. Transl. Med. 2006, 4:50.
19. Marioni J.C., Mason C.E., Mane S.M., Stephens M., Gilad Y. RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome Res. 2008, 18:1509-1517.
20. Meyerson M., Gabriel S., Getz G. Advances in understanding cancer genomes through second-generation sequencing. Nat. Rev. Genet. 2010, 11:685-696.
21. Mortazavi A., Williams B.A., McCue K., Schaeffer L., Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 2008, 5:621-628.
22. Oliver H., Orsi R., Ponnala L., Keich U., Wang W., Sun Q., Cartinhour S., Filiatrault M., Wiedmann M., Boor K. Deep RNA sequencing of L. monocytogenes reveals overlapping and extensive stationary phase and sigma B-dependent transcriptomes, including multiple highly transcribed noncoding RNAs. BMC Genomics 2009, 10:641.
23. Payne A.S., Cornelius L.A. The role of chemokines in melanoma tumor growth and metastasis. J. Invest. Dermatol. 2002, 118:915-922.
24. Pouyssegur J., Dayan F., Mazure N.M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 2006, 441:437-443.
25. Qian B.Z., Pollard J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141:39-51.
26. Radhakrishnan A., Badhrinarayanan N., Biswas J., Krishnakumar S. Analysis of chromosomal aberration (1, 3, and 8) and association of microRNAs in uveal melanoma. Mol. Vis. 2009, 15:2146-2154.
27. Rakosy Z., Vizkeleti L., Ecsedi S., Begany A., Emri G., Adany R., Balazs M. Characterization of 9p21 copy number alterations in human melanoma by fluorescence in situ hybridization. Cancer Genet. Cytogenet. 2008, 182:116-121.
28. Ramskold D., Luo S., Wang Y.C., Li R., Deng Q., Faridani O.R., Daniels G.A., Khrebtukova I., Loring J.F., Laurent L.C., et al. Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat. Biotechnol. 2012, 30:777-782.
29. Sano M., Aoyagi K., Takahashi H., Kawamura T., Mabuchi T., Igaki H., Tachimori Y., Kato H., Ochiai A., Honda H., et al. Forkhead box A1 transcriptional pathway in KRT7-expressing esophageal squamous cell carcinomas with extensive lymph node metastasis. Int. J. Oncol. 2010, 36:321-330.
30. Santos G.C., Zielenska M., Prasad M., Squire J.A. Chromosome 6p amplification and cancer progression. J. Clin. Pathol. 2007, 60:1-7.
31. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 2003, 3:721-732.
32. Semenza G.L. Hypoxia and cancer. Cancer Metastasis Rev. 2007, 26:223-224.
33. Shen Z.L., Kauttu T., Seppanen H., Vainionpaa S., Ye Y.J., Wang S., Mustonen H., Puolakkainen P. Both macrophages and hypoxia play critical role in regulating invasion of gastric cancer in vitro. Acta Oncol. 2013, 52:852-860.
34. Smith A.P., Hoek K., Becker D. Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas. Cancer Biol. Ther. 2005, 4:1018-1029.
35. Udart M., Utikal J., Krahn G.M., Peter R.U. Chromosome 7 aneusomy. A marker for metastatic melanoma? Expression of the epidermal growth factor receptor gene and chromosome 7 aneusomy in nevi, primary malignant melanomas and metastases. Neoplasia 2001, 3:245-254.
36. Waugh D.J., Wilson C. The interleukin-8 pathway in cancer. Clin. Cancer Res. 2008, 14:6735-6741.
37. Winnepenninckx V., Lazar V., Michiels S., Dessen P., Stas M., Alonso S.R., Avril M.F., Ortiz Romero P.L., Robert T., Balacescu O., et al. Gene expression profiling of primary cutaneous melanoma and clinical outcome. J. Natl. Cancer Inst. 2006, 98:472-482.
38. Wu J., Habegger L., Noisa P., Szekely A., Qiu C., Hutchison S., Raha D., Egholm M., Lin H., Weissman S. Dynamic transcriptomes during neural differentiation of human embryonic stem cells revealed by short, long, and paired-end sequencing. Proc. Natl. Acad. Sci. 2010, 107:5254.